Genetic Profiling Lung Tumors To Determine Best Chemotherapy Options
Filed in archive Drugs, Vaccines and Therapeutics , Genomics, Proteomics and Bioinformatics on September 30, 2007
Researchers are exploring the use of genetic profiling in lung tumors to to predict the tumors' likely response to therapy and determine the best treatment strategy for lung cancers.

Researchers looked at the sensitivity of multiple cancerous cell lines to cisplatin, the most commonly used agent in the treatment of lung cancer. After determining which cell lines were responsive to cisplatin they looked at the RNA of these tumors and generated a genomic signature - a pattern of gene expression particular to each individual sample. They were able to draw conclusions about which genes were turned on and which were turned off in these samples, and subsequently created a genomic map for cisplatin sensitivity. The genomic map was then applied to 91 non-small cell lung cancer (NSCLC) tumor samples to determine which tumors were most likely to be responsive to cisplatin, Hsu said.
For tumors that are unlikely to respond to cisplatin, a drug called pemetrexed may be a viable option, considering that the researchers foung strongest inverse correlation between tumors that were sensitive to cisplatin and those that were sensitive to pemetrexed. A clinical trial based on these findings are currently underway.
Source: Duke Med
Image: Medline Plus
Tags: cancer lung+cancer chemotherapy genomics lung genetic+profiling lung+tumors
Vote for Genetic Profiling Lung Tumors To Determine Best Chemotherapy Options:
|
Rating: 8.14 out of 7 vote(s) cast.
|
Most Popular
Best of
Biotech Hubs and Facilities
Biotech/Science Blogs
Corporate and Industrial News
Diagnostics, Methodologies and Instrumentation
Did you know
Drugs, Vaccines and Therapeutics
Energy, Environment and Ecology
Food and Agriculture
Gene Therapy
Genomics, Proteomics and Bioinformatics
Information About
Meetings and Other Events
Microbiology
Misc
Nanomedicine
Other Biotechnology News
Patents and Intellectual Property Rights
Quick introduction
Stem Cells
